Atsushi Shinagawa
Hitachi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
TCL1-family negative T-cell prolymphocytic leukemia with rapid progression of extranodal disease despite a normal white blood cell count
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 03, 2024
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
Journal: International journal of hematology
Published: May 09, 2024
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Journal: Cancer reports (Hoboken, N.J.)
Published: July 05, 2023
Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 13, 2023
Follicular lymphoma with secondary central nervous system relapse: a case report and literature review.
Journal: Oxford medical case reports
Published: April 06, 2023
FIP1L1::PDGFRA-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 18, 2023
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Journal: Japanese journal of clinical oncology
Published: November 17, 2022
Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 04, 2022
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
Journal: NPJ systems biology and applications
Published: February 22, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 29, 2021
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
Journal: Japanese journal of clinical oncology
Published: August 11, 2021
Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis during consolidation chemotherapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 09, 2020
Last Updated: 09/26/2026